ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NICE approves new tolerable drug carflizomib for multiple myeloma patients on NHS
July 25, 2017UK’s National Institute for Health and Care Excellence (NICE) has approved Amgen’s new anti-cancer treatment carflizomib for multiple myeloma patients on the National Health Service (NHS). -
FDA Accepts Amgen's Supplemental Biologics License Application to Expand Indication for Xgeva to Inc
June 22, 2017Amgen announced the U.S. Food and Drug Administration (FDA) has accepted the Xgeva (denosumab) supplemental Biologics License Application (sBLA) that seeks to expand the currently approved indication for the prevention of fractures and other skeletal-rela
Pharma Sources Insight January 2025
